Skip to main content
TipRanks
Go Ultimate75% OFF

Christopher Phillip.Anthony Weston Insider Profile

4 Followers

Christopher Phillip.Anthony Weston, Divisional Managing Director at Centrica, holds 102.68K shares in Aggreko (Ticker: ARGKF), holds 525.60K shares in Centrica (Ticker: GB:CNA).

Christopher Phillip.Anthony Weston's Trading History

ARGKF
Aggreko
Jun 02, 2021―Uninformative Buy10.23K$1.24M
CNA
Centrica
May 16, 2014Divisional Managing DirectorInformative Sell327.95K£820.98K

You May Also Like

Christopher Phillip.Anthony Weston insider profile FAQ

What is the percentage of profitable transactions made by Christopher Phillip.Anthony Weston?
The percentage of profitable transactions made by Christopher Phillip.Anthony Weston is 67%.
What is the average return per transaction made by Christopher Phillip.Anthony Weston?
The average return per transaction made by Christopher Phillip.Anthony Weston is -7.70%.
What stocks does Christopher Phillip.Anthony Weston hold?
Christopher Phillip.Anthony Weston holds: GB:CNA, ARGKF stocks.
What was Christopher Phillip.Anthony Weston’s latest transaction?
Christopher Phillip.Anthony Weston’s latest transaction was an Uninformative Buy of $10.23K.
What was Christopher Phillip.Anthony Weston's most profitable transaction?
Christopher Phillip.Anthony Weston’s most profitable transaction was an Informative Sell of ARGKF stock on April 4, 2016. The return on the trade was 26.20%.
What is Christopher Phillip.Anthony Weston's role in Centrica?
Christopher Phillip.Anthony Weston's role in Centrica is Divisional Managing Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.